Corrado Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
Sell
-49,775
Closed -$315K 109
2016
Q4
$315K Sell
49,775
-45,395
-48% -$287K 0.2% 82
2016
Q3
$420K Sell
95,170
-20,530
-18% -$90.6K 0.27% 65
2016
Q2
$329K Sell
115,700
-3,425
-3% -$9.74K 0.21% 71
2016
Q1
$337K Buy
119,125
+11,230
+10% +$31.8K 0.22% 66
2015
Q4
$1.11M Sell
107,895
-7,015
-6% -$72.4K 0.65% 36
2015
Q3
$1.31M Buy
114,910
+86,050
+298% +$981K 0.74% 32
2015
Q2
$431K Buy
+28,860
New +$431K 0.19% 63
2014
Q4
Sell
-14,750
Closed -$144K 71
2014
Q3
$144K Buy
+14,750
New +$144K 0.06% 67